Aptus Capital Advisors, LLC Johnson & Johnson Transaction History

Aptus Capital Advisors, LLC

$4.95 Billion
Q1 2024

A detailed history of Aptus Capital Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 84,633 shares of JNJ stock, worth $12.4 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

84,633

Previous 74,234 14.01%

Holding current value

$12.4 Million

Previous $11.6 Million 15.07%

% of portfolio

0.27%

Previous 0.33%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $1.61 Million - $1.69 Million	10,399 Added 14.01%	84,633 $13.4 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $1.22 Million - $1.33 Million	-8,349 Reduced 10.11%	74,234 $11.6 Million
Q3 2023 Nov 08, 2023	BUY	$155.75 - $174.48 $520,983 - $583,635	3,345 Added 4.22%	82,583 $12.9 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $651,820 - $701,482	-4,223 Reduced 5.06%	79,238 $13.1 Million
Q1 2023 May 09, 2023	SELL	$151.05 - $180.26 $794,069 - $947,626	-5,257 Reduced 5.93%	83,461 $12.9 Million

Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $1.8 Million - $2.02 Million	11,218 Added 14.47%	88,718 $15.7 Million
Q3 2022 Nov 02, 2022	BUY	$161.33 - $179.52 $835,205 - $929,375	5,177 Added 7.16%	77,500 $12.7 Million
Q2 2022 Jul 29, 2022	BUY	$168.19 - $186.01 $1.02 Million - $1.13 Million	6,054 Added 9.14%	72,323 $12.8 Million
Q1 2022 May 04, 2022	BUY	$158.14 - $179.59 $1.65 Million - $1.87 Million	10,440 Added 18.7%	66,269 $11.7 Million
Q4 2021 Feb 02, 2022	BUY	$155.93 - $173.01 $342,734 - $380,275	2,198 Added 4.1%	55,829 $9.55 Million
Q3 2021 Oct 27, 2021	BUY	$161.5 - $179.47 $1.14 Million - $1.26 Million	7,048 Added 15.13%	53,631 $8.66 Million
Q2 2021 Jul 27, 2021	BUY	$159.48 - $171.07 $715,108 - $767,077	4,484 Added 10.65%	46,583 $7.67 Million
Q1 2021 May 06, 2021	SELL	$153.07 - $170.48 $774,687 - $862,799	-5,061 Reduced 10.73%	42,099 $6.92 Million
Q4 2020 Feb 10, 2021	BUY	$137.11 - $157.38 $889,158 - $1.02 Million	6,485 Added 15.94%	47,160 $7.42 Million
Q3 2020 Oct 19, 2020	BUY	$140.38 - $153.83 $377,481 - $413,648	2,689 Added 7.08%	40,675 $6.06 Million
Q2 2020 Jul 22, 2020	SELL	$128.81 - $155.51 $55,388 - $66,869	-430 Reduced 1.12%	37,986 $5.34 Million
Q1 2020 May 07, 2020	SELL	$111.14 - $153.99 $563,368 - $780,575	-5,069 Reduced 11.66%	38,416 $5.04 Million
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $2.59 Million - $2.98 Million	20,332 Added 87.82%	43,485 $6.34 Million
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $2.14 Million - $2.39 Million	16,819 Added 265.54%	23,153 $3 Million
Q2 2019 Aug 13, 2019	SELL	$131.15 - $144.24 $128,002 - $140,778	-976 Reduced 13.35%	6,334 $882,000
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $919,013 - $1.02 Million	7,310 New	7,310 $1.02 Million

Others Institutions Holding JNJ

# of Institutions

4,148

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $383B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Account

Aptus Capital Advisors, LLC Johnson & Johnson Transaction History